INTRODUCTION: The systematic collection of electronic patient-reported outcome (ePRO) in the routine care of patients with chronic haematological malignancies such as chronic lymphocytic leukaemia (CLL) and myelodysplasia syndromes (MDS) can constitute a very ambitious but worthwhile challenge. MyPal is a Horizon 2020 Research & Innovation Action aiming to meet this challenge and foster palliative care for patients with CLL or MDS by leveraging ePRO systems to adapt to the personal needs of patients and caregiver(s). METHODS AND ANALYSIS: In this interventional randomised trial, 300 patients with CLL or MDS will be recruited across Europe. Patients will be randomly allocated to early palliative care using the MyPal system (n=150) versus standard care including general palliative care if needed (n=150). Patients in the experimental arm will be given access to the MyPal digital health platform which consists of purposely designed software available on smartphones and/or tablets. The platform entails different functionalities including physical and psychoemotional symptom reporting via regular questionnaire completion, spontaneous self-reporting, motivational messages, medication management and a personalised search engine for health information. Data on patients' activity (daily steps and sleep quality) will be automatically collected via wearable devices. ETHICS AND DISSEMINATION: The integration of ePROs via mobile applications has raised ethical concerns regarding inclusion criteria, information provided to participants, free and voluntary consent, and respect for their autonomy. These have been carefully addressed by a multidisciplinary team. Data processing, dissemination and exploitation of the study findings will take place in full compliance with European Union data protection law. A participatory design was adopted in the development of the digital platform involving focus groups and discussions with patients to identify needs and preferences. The protocol was approved by the ethics committees of San Raffaele (8/2020), Thessaloniki 'George Papanikolaou' Hospital (849), Karolinska Institutet (20.10.2020), University General Hospital of Heraklion (07/15.4.2020) and University of Brno (01-120220/EK). TRIAL REGISTRATION NUMBER: NCT04370457.

Clinical Genetics Karolinska University Hospital Stockholm Sweden

Department of Haematology and Oncology University Hospital Brno Brno Czech Republic

Department of Hematology University Hospital of Heraklion Heraklion Greece

Department of Hematology University of Crete School of Medicine Heraklion Crete Greece

Department of Molecular Medicine and Surgery Karolinska Institute Stockholm Sweden

Department of Public Health Policy University of West Attica Athens Greece

G Papanicolaou Hospital Thessaloniki Greece

Head Office European Association for Palliative Care Vilvoorde Belgium

Institute of Applied Biosciences Centre for Research and Technology Hellas Thessaloniki Greece

Internal Medicine Vita Salute San Raffaele University Milan Italy

International Observatory on End of Life Care University of Lancaster Lancaster UK

Medical Oncology Vita Salute San Raffaele University Milan Italy

Strategic Research Program on CLL IRCCS San Raffaele Hospital Milan Italy

Zobrazit více v PubMed

Hallek M. Chronic lymphocytic leukemia: 2015 update on diagnosis, risk stratification, and treatment. Am J Hematol 2015;90:446–60. 10.1002/ajh.23979 PubMed DOI

Neukirchen J, Schoonen WM, Strupp C, et al. . Incidence and prevalence of myelodysplastic syndromes: data from the Düsseldorf MDS-registry. Leuk Res 2011;35:1591–6. 10.1016/j.leukres.2011.06.001 PubMed DOI

Scheffold A, Stilgenbauer S. Revolution of chronic lymphocytic leukemia therapy: the Chemo-Free treatment paradigm. Curr Oncol Rep 2020;22:16. 10.1007/s11912-020-0881-4 PubMed DOI PMC

Molica S. Quality of life in chronic lymphocytic leukemia: a neglected issue. Leuk Lymphoma 2005;46:1709–14. 10.1080/10428190500244183 PubMed DOI

Else M, Smith AG, Cocks K, et al. . Patients' experience of chronic lymphocytic leukaemia: baseline health-related quality of life results from the LRF CLL4 trial. Br J Haematol 2008;143:690–7. 10.1111/j.1365-2141.2008.07407.x PubMed DOI

Steensma DP, Heptinstall KV, Johnson VM, et al. . Common troublesome symptoms and their impact on quality of life in patients with myelodysplastic syndromes (MDS): results of a large Internet-based survey. Leuk Res 2008;32:691–8. 10.1016/j.leukres.2007.10.015 PubMed DOI

Efficace F, Gaidano G, Breccia M, et al. . Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes. Br J Haematol 2015;168:361–70. 10.1111/bjh.13138 PubMed DOI

Cannella L, Caocci G, Jacobs M, et al. . Health-Related quality of life and symptom assessment in randomized controlled trials of patients with leukemia and myelodysplastic syndromes: what have we learned? Crit Rev Oncol Hematol 2015;96:542–54. 10.1016/j.critrevonc.2015.07.012 PubMed DOI

Basch E, Abernethy AP, Mullins CD, et al. . Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. J Clin Oncol 2012;30:4249–55. 10.1200/JCO.2012.42.5967 PubMed DOI

Kluetz PG, Chingos DT, Basch EM. Patient-reported outcomes in cancer clinical trials: measuring symptomatic adverse events with the national cancer institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Am Soc Clin Oncol Educ Book 2016;2016:67–73. 10.1200/EDBK_159514 PubMed DOI

Dudgeon D. The impact of measuring patient-reported outcome measures on quality of and access to palliative care. J Palliat Med 2018;21:S-76–S-80. 10.1089/jpm.2017.0447 PubMed DOI PMC

Antunes B, Harding R, Higginson IJ, et al. . Implementing patient-reported outcome measures in palliative care clinical practice: a systematic review of facilitators and barriers. Palliat Med 2014;28:158–75. 10.1177/0269216313491619 PubMed DOI

Bausewein C, Daveson B, Benalia H, et al. . Outcome measurement in palliative care: the essentials. PRISMA 2011:1–48.

World Health Organization . WHO guideline: recommendations on digital interventions for health system strengthening web supplement 2: summary of findings and grade tables. World Health Organization, 2019. PubMed

Wright AA, Raman N, Staples P, et al. . The hope pilot study: harnessing patient-reported outcomes and biometric data to enhance cancer care. JCO Clin Cancer Inform 2018;2:1–12. 10.1200/CCI.17.00149 PubMed DOI PMC

Maguire R, Ream E, Richardson A, et al. . Development of a novel remote patient monitoring system: the advanced symptom management system for radiotherapy to improve the symptom experience of patients with lung cancer receiving radiotherapy. Cancer Nurs 2015;38:E37–47. 10.1097/NCC.0000000000000150 PubMed DOI

Sundberg K, Wengström Y, Blomberg K, et al. . Early detection and management of symptoms using an interactive smartphone application (Interaktor) during radiotherapy for prostate cancer. Support Care Cancer 2017;25:2195–204. 10.1007/s00520-017-3625-8 PubMed DOI PMC

Jibb LA, Stevens BJ, Nathan PC, et al. . Implementation and preliminary effectiveness of a real-time pain management smartphone APP for adolescents with cancer: a multicenter pilot clinical study. Pediatr Blood Cancer 2017;64:e26554. 10.1002/pbc.26554 PubMed DOI

Fayers P, Bottomley A. Quality of life research within the EORTC—the EORTC QLQ-C30. Eur J Cancer 2002;38:125–33. 10.1016/S0959-8049(01)00448-8 PubMed DOI

Rabin R, Gudex C, Selai C, et al. . From translation to version management: a history and review of methods for the cultural adaptation of the EuroQol five-dimensional questionnaire. Value Health 2014;17:70–6. 10.1016/j.jval.2013.10.006 PubMed DOI

Hearn J, Higginson IJ. Development and validation of a core outcome measure for palliative care: the palliative care outcome scale. palliative care core audit project Advisory group. Qual Health Care 1999;8:219–27. 10.1136/qshc.8.4.219 PubMed DOI PMC

Brédart A, Anota A, Young T, et al. . Phase III study of the European organisation for research and treatment of cancer satisfaction with cancer care core questionnaire (EORTC PATSAT-C33) and specific complementary outpatient module (EORTC OUT-PATSAT7). Eur J Cancer Care 2018;27:e12786. 10.1111/ecc.12786 PubMed DOI

Bruera E, Kuehn N, Miller MJ, et al. . The Edmonton symptom assessment system (ESAs): a simple method for the assessment of palliative care patients. J Palliat Care 1991;7:6–9. 10.1177/082585979100700202 PubMed DOI

Cleeland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med Singap 1994;23:129–38. PubMed

Mitchell AJ, Baker-Glenn EA, Granger L, et al. . Can the distress thermometer be improved by additional mood domains? Part I. Initial validation of the emotion thermometers tool. Psychooncology 2010;19:125–33. 10.1002/pon.1523 PubMed DOI

Efird J. Blocked randomization with randomly selected block sizes. Int J Environ Res Public Health 2011;8:15–20. 10.3390/ijerph8010015 PubMed DOI PMC

Cavoukian A. Privacy by design: the 7 foundational principles. information and privacy commissioner of Ontario, Canada, 2009. Available: https://www.ipc.on.ca/wp-content/uploads/resources/7foundationalprinciples.pdf

Regulation P. regulation (EU) 2016/679 of the European parliament and of the council. Regulation (EU), 2016. Available: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32016R0679

Ernst J, Kuhnt S, Schwarzer A, et al. . The desire for shared decision making among patients with solid and hematological cancer. Psychooncology 2011;20:186–93. 10.1002/pon.1723 PubMed DOI

Payne S, Tanner M, Hughes S. Digitisation and the patient–professional relationship in palliative care 2020:441–3. doi:10.1177%2F0269216320911501 PubMed

Perceptions and Needs of Stakeholders Regarding MyPal Project's Electronic Patient-Reported Outcome App: Cross-Sectional Qualitative Focus Group Study

Zobrazit více v PubMed

ClinicalTrials.gov
NCT04370457